Head-to-head · WeighScore
REMEVi vs Teladoc Health
The verdict
REMEVi takes it — 70.4/100 to 55.9/100.
REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | REMEVi | Teladoc Health |
|---|---|---|
| WeighScore | 70.4/100 | 55.9/100 |
| Grade | C | C |
| Scorecard rank | #105 | #429 |
| Semaglutide | $199/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $269/mo (starting dose, compounded) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #105 · C
Strengths
- The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
- Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
- LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
- Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)
Where it loses points
- Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
- Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
- The specific compounding pharmacy is not named (described as 'NPI-verified')
- A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements
Graded #429 · C
Strengths
- Dedicated GLP-1 Prescription and Support program for weight management
- Backed by one of the largest virtual care companies in the US
- Partners with 50%-plus of Fortune 500 and 100-plus health plans
- Adds nutrition, coaching and connected device tracking
- Strong clinical credibility and brand trust
Where it loses points
- Distributed mainly via employers and health plans, limited direct cash-pay
- No transparent published monthly price for GLP-1 care
- Specific medications and eligibility vary by plan coverage
- Member experience can depend on the employer's chosen configuration
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.